TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $124,214,000 | +48.3% | 1,650,689 | -47.1% | 0.01% | +75.0% |
| Q1 2022 | $83,770,000 | -22.8% | 3,119,926 | +37.2% | 0.00% | -20.0% |
| Q4 2021 | $108,495,000 | +4.2% | 2,274,518 | +45.1% | 0.01% | -16.7% |
| Q3 2021 | $104,166,000 | -8.3% | 1,568,053 | +7.7% | 0.01% | 0.0% |
| Q2 2021 | $113,584,000 | +4.5% | 1,455,833 | +26.6% | 0.01% | 0.0% |
| Q1 2021 | $108,737,000 | -29.1% | 1,149,563 | -8.7% | 0.01% | -33.3% |
| Q4 2020 | $153,375,000 | +37.5% | 1,258,720 | -1.4% | 0.01% | +12.5% |
| Q3 2020 | $111,515,000 | +50.6% | 1,276,504 | +11.4% | 0.01% | +60.0% |
| Q2 2020 | $74,043,000 | +55.1% | 1,146,356 | +7.3% | 0.01% | +25.0% |
| Q1 2020 | $47,729,000 | -25.8% | 1,068,714 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $64,324,000 | +356.5% | 1,032,651 | +175.6% | 0.00% | +300.0% |
| Q3 2019 | $14,090,000 | +252.3% | 374,730 | +281.4% | 0.00% | – |
| Q2 2019 | $3,999,000 | – | 98,247 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |